2018
DOI: 10.1016/j.jddst.2018.10.011
|View full text |Cite
|
Sign up to set email alerts
|

State-of-art based approaches for anticancer drug-targeting to nucleus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 78 publications
0
6
0
1
Order By: Relevance
“…Their moderate tumor uptake may be due to the limited binding rate with the nuclear receptors and rapid metabolism. Effective drug delivery to the nucleus is a challenge because of various physiological barriers, which provide a broader platform for cancer diagnosis and treatment by enhancing nuclear uptake and reducing uptake of normal tissues . In this study, a novel radioiodinated progesterone derivative conjugated with PEGylated phenylboronic acid ( 131 I‐EIPBA) was prepared to enhance the nucleus uptake, and the feasibility of PR targeting was demonstrated in vitro and in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…Their moderate tumor uptake may be due to the limited binding rate with the nuclear receptors and rapid metabolism. Effective drug delivery to the nucleus is a challenge because of various physiological barriers, which provide a broader platform for cancer diagnosis and treatment by enhancing nuclear uptake and reducing uptake of normal tissues . In this study, a novel radioiodinated progesterone derivative conjugated with PEGylated phenylboronic acid ( 131 I‐EIPBA) was prepared to enhance the nucleus uptake, and the feasibility of PR targeting was demonstrated in vitro and in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…Cell-labeling dyes represent a good study model thanks to their (i) easy monitoring through fluorescence, (ii) high Raman cross sections, (iii) specificity toward given cellular compartments, and (iv) sizes comparable to that of therapeutic drugs. The nuclear labeling dye DAPI was chosen as a model study for therapeutic drugs, which normally target the cellular machinery inside the nucleus. , Concurrently, the membrane labeling DiO was selected as a representative for high-interest therapeutic agents targeting the plasma membrane. Accordingly, prior to the endoscopy experiments, the nucleus or plasma membrane were labeled with DAPI or DiO, respectively. Investigations through Raman spectroscopy require reference spectra of the compounds under study, to be compared with the spectra obtained via endoscopy.…”
Section: Methodsmentioning
confidence: 99%
“…The nuclear labeling dye DAPI was chosen as a model study for therapeutic drugs, which normally target the cellular machinery inside the nucleus. 28,29 Concurrently, the membrane labeling DiO was selected as a representative for high-interest therapeutic agents targeting the plasma membrane. 30−32 Accordingly, prior to the endoscopy experiments, the nucleus or plasma membrane were labeled with DAPI or DiO, respectively.…”
Section: ■ Materials and Methodsmentioning
confidence: 99%